SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Small Cap Foreign Biotech
An SI Board Since January 2000
Posts SubjectMarks Bans
363 30 0
Emcee:  RWReeves Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
313Nigel, Well, Protherics is an interesting find outside of the BSE story. As youRWReeves-2/11/2004
312UK surgical implant minnow Tissue Science Laboratories might be worth a look ? nigel bates-2/6/2004
311I am hanging on to mine pending partnership agreement and or phase 2 results. Itscott mcdowell-2/4/2004
310Pop up alert: Although quotes for Conjuchem are showing at 7.6 I've just solRWReeves-2/4/2004
309Vernalis is perhaps starting to look interesting again. No-one is getting excitenigel bates-1/30/2004
308Well Nigel, this looks like an interesting find indeed. Wish I'd been payingRWReeves-1/29/2004
307And the long (medium?) term case for Protherics (though with a market cap. of arnigel bates-1/26/2004
306<i>Top-sliced my Protherics holding as it reacted to this (will hold the rnigel bates-1/15/2004
305BTG Announces Acquisition Of Three Alzheimer's Disease Compounds From Sankyokeokalani'nui-11/6/2003
304Yes,I think they will do fine over the long term.IMO.thebeach-10/21/2003
303Hello beach,I came within a wisker of selling this, this morning @ $1.03 but didgg cox-10/21/2003
302Confirmation of what should be decent results from Protherics: <i>MELVILLnigel bates-10/15/2003
301NeuTec Pharma to seek development partners for Mycograb(R) in cancer (Just parkinigel bates-10/6/2003
300stockhouse.com Invitation to Participate in a Conference Call - Procyon to Discthebeach-9/28/2003
299Procyon Biopharma (PBP-TSE) On October 1st, Hans J. Mader along with Procyonthebeach-9/26/2003
298Ron has quite a following. I followed the Amylin version of story while at J&amRWReeves-9/3/2003
297conjuchem CJC.TO was recommended today by Ron Garren of biotech insight here is scott mcdowell-8/29/2003
296Protherics acquisition of Enact begins to look quite smart (this seems to be onenigel bates-8/28/2003
295Artimplant’s Spacer CMC-I approved for marketing in Europe 2003-08-18 12:56 ArtIcebrg-8/18/2003
294Medivir licenses MIV-150 to Population Council 2003-07-30 MIV-150 has been outlIcebrg-7/30/2003
293Medivir, Boehringer Ingelheim Enter Potential EUR122M Alliance By Cormac SheridIcebrg-7/19/2003
292Boehringer Ingelheim and Medivir sign agreement for novel HIV/AIDS antiviral 200Icebrg-7/15/2003
291IMI.TO going up in anticipation of American assoc. of cancer research meeting thscott mcdowell-7/9/2003
290Medivir Q2 report PRESS RELEASE, 9 July 2003 INTERIM REPORT, 1 January - 30 JuIcebrg-7/9/2003
289>> Active Biotech up 20% in Europe.>> They fell back again - to 12 Icebrg-7/4/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News